Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LINC01296
   Synonyms DUXAP9, LINC01296, FLJ39632, lncRNA-CTD903
   Region GRCh38_14:19062316-19131167    Sequence
   Ensembl ENSG00000225210
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name colon cancer
   ICD-0-3 C18  
   Methods qPCR, RIP etc.
   Sample colon carcinoma tissues, cell lines(CCD841a, SW480, DLD-1, HCT116, SW620, Caco-2 and HT29)
   Expression Pattern up-regulated
   Function Description

LINC01296 was upregulated in CC cancerous tissues and cell lines compared to adjacent normal tissue and normal liver cell lines. Besides, LINC01296 overexpression was associated with poor prognostic and lower survival rate.Moreover, LINC01296 silencing inhibited the proliferation, invasion of CC cells in vitro detected by epithelialmesenchymal transition (EMT). Bioinformatics analysis revealed that miR-21a targeted 3'-UTR of LINC01296. Rescue experiments confirmed that miR-21a could reverse the function of LINC01296 on CC cells.The expression of LINC01296 and mir-21a is negatively correlated in CC.

   Pubmed ID 29673421
   Year 2018
   Title Long noncoding RNA LINC01296 harbors miR-21a to regulate colon carcinoma proliferation and invasion.
   External Links
   Links for  LINC01296 GenBank       HGNC       lncrnadb       Noncode
   Links for  colon cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.